LOXL2 and neoplasm: These results indicated that nuclear LOXL-2 might have some protective role against esophageal SCC.Altered tissue architecture in tumors affecting mammary and gastric glands leads to interaction between membrane bound LOXL-2 and tumor matrix, facilitating metastatic behavior (Hollosi et al., 2009).